Germline breast cancer susceptibility gene 1/2 (BRCA1/2) variation is known to increase the lifetime risk of several cancers, such as breast cancer and ovarian cancer [46], and has been well investigated for its highly ethnic-specific in Ashkenazi Jewish and Polish populations [47]. This evidence concerns the gene BRCA1 and ovarian cancer.